Combilytics develops EternLFX, a natural senolytic formula that combines Quercetin and Fisetin to selectively eliminate senescent cells, which contribute to age-related health decline. This solution aims to enhance health span and potentially extend lifespan by improving cellular function and reducing the accumulation of harmful zombie cells.
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
As we age, some cells cease replicating but remain alive, becoming senescent or "zombie" cells that release harmful substances. These senescent cells contribute to age-related health decline and can accelerate the aging process. The accumulation of these cells can lead to various health issues and a reduced healthspan.
Solution
Combilytics develops EternLFX, a natural senolytic formula designed to selectively eliminate senescent cells from the body. EternLFX combines Quercetin and Fisetin, two natural compounds that have demonstrated the ability to target and clear senescent cells. By removing these harmful cells, EternLFX aims to slow down epigenetic aging, support mitochondrial health, increase telomere length, reduce glycation, and boost brain health. This approach seeks to improve overall cellular function, increase healthspan, and potentially extend lifespan by addressing a root cause of aging.
Target Audience
EternLFX is targeted towards individuals seeking to proactively address the effects of aging at a cellular level and improve their overall healthspan.
Features
- Combines Quercetin and Fisetin, two well-regarded natural senolytics.
- Selectively targets and eliminates senescent "zombie" cells.
- Supports mitochondrial health and function.
- Increases telomere length, a marker of cellular aging.
- Reduces glycation, a process that damages proteins and contributes to aging.
- Boosts cognitive function and brain health.